| Vol. 8.21 – 19 June, 2023 |
| |
|
|
| Investigators used a combination of induced pluripotent stem cell (iPSC)-based disease modeling and CRISPR/Cas9-mediated genome editing to generate patient-specific cardiomyocytes and isogenic controls lacking the pathogenic MYBPC3 variant. [Circulation Research] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Researchers investigated subcellular iron uptake mechanisms in patient-derived and CRISPR/Cas–edited induced pluripotent stem cell–derived cardiomyocytes, as well as in patient-derived heart tissue. They used an integrated platform of MS-DIA–based proteomics and signaling pathway interrogation. [Circulation Research] |
|
|
|
| Scientists showed that transcript induced in spermiogenesis 40 (Tisp40) expression, cleavage, and nuclear accumulation were increased by cardiac ischemia/reperfusion (I/R) injury. Overexpression of nuclear Tisp40 was sufficient to attenuate cardiac I/R injury in vivo and in vitro. [Nature Communications] |
|
|
|
| Peroxisome proliferator-activated receptor (Ppara) disruption in cardiomyocytes augmented mitochondrial dysfunction, as revealed by damaged mitochondria, lowered ATP contents, decreased mitochondrial complex activities, and increased DRP1/MFN1 protein levels. [Acta Pharmacologica Sinica] |
| |
|
|
| Investigators provided a proteomic analysis of physiologically aged murine muscle stem cells (MuSCs), illustrating a pre-senescent proteomic signature. During aging, the mitochondrial proteome and activity were impaired in MuSCs. [Developmental Cell] |
|
|
|
| Researchers presented a muscular organoid produced from the bovine diaphragm, which had a peculiar multilayered structure with different fiber orientations depending on the considered area. [Journal Of Anatomy] |
| |
|
|
| Scientists compared the effects of zinc chelation or supplementation on total intracellular zinc content, antioxidant nuclear factor erythroid 2-related factor 2 (NRF2) targeted gene transcription, and hypoxia/reoxygenation-induced reactive oxygen species generation. [Redox Biology] |
|
|
|
| Treatment of human myometrial smooth muscle cells with L-arginine significantly inhibited spontaneous contractions by attenuating activation of NF-κB and downregulating the expression of contraction-associated protein genes. [EMBO Reports] |
|
|
|
| Scientists identified key factors associated with arteriovenous fistula outflow stenosis. They isolated vascular smooth muscle cells (VSMCs) from the inferior vena cava of wild-type and osteopontin-knockout mice and assessed the proliferation of VSMCs following stimulation with platelet-derived growth factors. [Microvascular Research] |
|
|
|
|
| The authors review genetic modifier studies in Duchenne muscular dystrophy to date and discuss the effect of genetic modifiers on predicting disease trajectories, clinical trial design and interpretation, and therapeutic approaches. [Nature Reviews Neurology] |
|
|
|
| Investigators review vascular smooth muscle cell (VSMC) mitochondrial metabolism in three aspects: mitochondrial ROS generation, mutated mitochondrial DNA, and calcium metabolism respectively. They also summarize the role of mitochondrial dynamics in regulating VSMC phenotypes. [Redox Biology] |
|
|
|
|
| CureDuchenne, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy, announced a collaborative clinical trial grant to test the repurposing of the FDA-approved drug Vyvgart, for its potential ability to reduce antibodies to adeno-associated virus in Duchenne muscular dystrophy patients. [CureDuchenne] |
|
|
|
|
| July 9 – 14, 2023 Barcelona, Spain |
|
|
|
|
|
| Monash University – Melbourne, Victoria, Australia |
|
|
|
| Novartis – Basel, Switzerland |
|
|
|
| University of Nevada – Reno, Nevada, United States |
|
|
|
| Loughborough University – Loughborough, England, United Kingdom |
|
|
|
| ETH Zurich – Zurich, Switzerland |
|
|
|
|